Health Care • Medical/Nursing Services
$6.88 ▼ -0.25
(-3.51%)
MKT CAP: $126.2M • VOL: 115.7K
52W L $3 52W H $37
NAKA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.8M | $2.7M | $3.8M |
| YoY Revenue Growth % | -33.0% | -27.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$197.1M | -$3.3M | -$1.6M |
| Operating Margin % | -80.0% | -80.0% | -43.0% |
| Net Income (GAAP) | -$52.2M | -$3.6M | -$1.6M |
| EBITDA (Normalized) | — | -$3.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$23.5M | -$3.1M | -$449.5K |
| Capital Expenditures (CapEx) | — | $13.3K | — |
| Free Cash Flow (FCF) | -$23.5M | -$3.1M | -$449.5K |
| FCF Margin % | -80.0% | -80.0% | -11.9% |
| Return on Invested Capital (ROIC %) | -31.6% | -45.0% | — |
| Cash & Short-Term Equivalents | $21.1M | $2.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $514.3M | $2.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NAKA.